Uworld Today

Every hour of delay in reperfusion increases mortality by 1.6%. Atypical MI patients receive fibrinolysis or percutaneous intervention (PCI) an average of 90 minutes later than classic-presenting patients. This “missed MI” leads to preventable heart failure, arrhythmias, and sudden death. In UWorld simulations, the best answer to “what is the most important next step?” is not “order a stress test” but rather “obtain serial troponins and an ECG” in suspected atypical cases. Conclusion The competent clinician does not wait for a textbook presentation. By embracing atypical symptoms, applying structured risk assessment, and maintaining a low threshold for cardiac biomarkers, providers can reduce diagnostic delays in MI. UWorld’s pedagogical emphasis on “next best step” and “most likely diagnosis” trains learners to think in probabilities, not certainties—a skill that directly translates to saved lives. As one UWorld question might conclude: When you hear hoofbeats, think horses, but never forget the zebras with diabetes.

Introduction Myocardial infarction (MI) remains a leading cause of morbidity worldwide, yet its presentation is not always the classic substernal chest pressure radiating to the left arm. Atypical symptoms—particularly in women, diabetics, and the elderly—frequently lead to delayed diagnosis and poorer outcomes. Effective clinical reasoning therefore requires moving beyond pattern recognition to a probabilistic, hypothesis-driven approach that integrates risk factors, subtle exam findings, and serial data. Body 1. The Pitfall of Typical-Only Thinking Novice practitioners often expect MI to present as sudden, crushing chest pain with diaphoresis. However, up to 40% of MIs, especially non-ST-elevation MIs (NSTEMI), present with isolated dyspnea, epigastric discomfort, nausea, or profound fatigue. A UWorld-style question might describe a 72-year-old diabetic woman with “indigestion” and no chest pain. The correct answer hinges on recognizing that diabetes causes autonomic neuropathy, blunting afferent pain signals. Thus, the absence of typical pain does not rule out MI—it shifts the pretest probability based on age, gender, and comorbidities. uworld